A growing body of evidence has suggested that oxidative stress is likely to play major a role in neuronal cell loss associated with PD. Alterations in levels of accessories reactive iron and the peroxide-scavenging antioxidant glutathione (GSH) in the PD brain have both been postulated to contribute to the loss of dopaminergic neurons of the substantia nigra (SN) associated with the disease via oxidative stress-related mechanisms. The investigators currently have two existing NIH grants to explore the effects of chronic alterations in brain iron levels via neonatal iron feeding in conjunction with transgenic mouse lines which display altered SN expression levels of the protective iron-storage protein ferritin and SN GSH levels via transgenic lines expressing antisense message against the glutathione-synthesizing enzyme glutamyl cysteine synthetase (antiGCS). These models are presently being used in conjunction with the well-established MPTP toxicity model of PD to test whether chronic alterations in SN iron or GSH levels alters age-related increases in nigrostriatal degeneration compound and whether this involves alterations of levels of either oxidative stress or mitochondrial dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54ES012077-01
Application #
6661798
Study Section
Special Emphasis Panel (ZES1)
Project Start
2002-08-26
Project End
2007-07-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Parkinson's Institute
Department
Type
DUNS #
614259935
City
Sunnyvale
State
CA
Country
United States
Zip Code
94085
Koga, Shunsuke; Aoki, Naoya; Uitti, Ryan J et al. (2015) When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology 85:404-12
Goldman, Samuel M; Kamel, Freya; Ross, G Webster et al. (2014) Peptidoglycan recognition protein genes and risk of Parkinson's disease. Mov Disord 29:1171-80
McGuire, V; Van Den Eeden, S K; Tanner, C M et al. (2011) Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. J Neurol Sci 307:22-9
Popat, R A; Van Den Eeden, S K; Tanner, C M et al. (2011) Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. Eur J Neurol 18:756-65
Quik, Maryka; Campos, Carla; Parameswaran, Neeraja et al. (2010) Chronic nicotine treatment increases nAChRs and microglial expression in monkey substantia nigra after nigrostriatal damage. J Mol Neurosci 40:105-13
Peng, Jun; Oo, May Lin; Andersen, Julie K (2010) Synergistic effects of environmental risk factors and gene mutations in Parkinson's disease accelerate age-related neurodegeneration. J Neurochem 115:1363-73
Mak, Sally K; McCormack, Alison L; Manning-Bog, Amy B et al. (2010) Lysosomal degradation of alpha-synuclein in vivo. J Biol Chem 285:13621-9
Kaur, Deepinder; Rajagopalan, Subramanian; Andersen, Julie K (2009) Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease. Brain Res 1297:17-22
Chinta, Shankar J; Rane, Anand; Yadava, Nagendra et al. (2009) Reactive oxygen species regulation by AIF- and complex I-depleted brain mitochondria. Free Radic Biol Med 46:939-47
Peng, Jun; Stevenson, Fang Feng; Oo, May Lin et al. (2009) Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation. Free Radic Biol Med 46:312-20

Showing the most recent 10 out of 39 publications